Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,258
Total Claims
$1.4M
Drug Cost
1,401
Beneficiaries
$1,017
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 4,479 Interventional Cardiology providers
-4%
Cost per patient vs peers
$1,017 vs $1,054 avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.8%
Opioid Rate
77
Opioid Claims
$684
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 0 claims · $0
Generic: 8,817 claims · $128K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 375 | $350K |
| Rivaroxaban | 320 | $326K |
| Riociguat | 13 | $173K |
| Evolocumab | 190 | $138K |
| Sacubitril/Valsartan | 32 | $37K |
| Dronedarone Hcl | 24 | $26K |
| Tirzepatide | 23 | $26K |
| Semaglutide | 21 | $20K |
| Bempedoic Acid/Ezetimibe | 31 | $20K |
| Empagliflozin | 21 | $18K |
| Alirocumab | 22 | $18K |
| Dapagliflozin Propanediol | 13 | $16K |
| Patiromer Calcium Sorbitex | 11 | $15K |
| Clopidogrel Bisulfate | 1,013 | $11K |
| Sitagliptin Phosphate | 14 | $10K |
Prescribing Profile
Patient Profile
75
Avg Age
52%
Female
1.44
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About